Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy-Reference-Cited by-同舟云学术

Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy

Published:2022-04-15 Issue:8 Volume:61 Page:1219-1223
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kitahara Asako¹,Ebihara Akinori²,Obayashi Shohei¹,Horio Yukihiro¹,Ono Yoshitaka¹,Yoshikawa Tomohiro¹,Okada Naoki¹,Tanaka Jun¹,Takiguchi Hiroto¹,Hayama Naoki¹,Ito Yoko¹,Oguma Tsuyoshi¹,Kuwahira Ichiro²,Asano Koichiro¹

Affiliation:

1. Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan

2. Division of Pulmonary Medicine, Department of Medicine, Tokai University Tokyo Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/8/61_8928-21/_pdf

Reference22 articles.

1. 1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054-1062, 2020.

2. 2. Garassino MC, Whisenant JG, Huang LC, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol 21: 914-922, 2020.

3. 3. Calabro L, Rossi G, Covre A, Morra A, Maio M. COVID and lung cancer. Curr Oncol Rep 23: 134, 2021.

4. 4. Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy 12: 269-273, 2020.

5. 5. Li Y, Zhao K, Wei H, et al. Dynamic relationship between D-dimer and COVID-19 severity. Br J Haematol 190: e24-e27, 2020.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Potential of Venn Diagrams as a Helpful Tool for Clinical Reasoning: An Illustrative Case-based Discussion;Current Problems in Diagnostic Radiology;2023-11

2. Antineoplastics/granulocyte colony-stimulating factors;Reactions Weekly;2022-05